Evidence map›Paper›PMID 31859669›Full record

ArticleInternational perspectives on sexual and reproductive health2019

Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa.

Felix G Mhlanga, Jennifer E Balkus, Devika Singh, Catherine Chappell, Betty Kamira, Ishana Harkoo, Daniel Szydlo, Shorai Mukaka, Jeanna Piper, Sharon L Hillier

Open access · greenAbstract read
In one paragraph

Article in International perspectives on sexual and reproductive health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Uterine Artery Rupture Caused by IUD Extraction: A Case Report.International journal of women's health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 4 countries.

Felix G MhlangaSenior Lecturer, University of Zimbabwe College of Health Sciences Clinical Trials Unit, Harare, Zimbabwe, fmhlanga@uzchs-ctrc.org.
Jennifer E BalkusAssistant Professor, Department of Epidemiology and Department of Global Health, University of Washington, Seattle, WA, USA.
Devika SinghSafety Researcher at the Microbicide Trials Network, Seattle, WA, USA.
Catherine ChappellAssistant Professor, Obstetrics, Gynecology and Reproductive Services, Magee-Women's Research Institute and Foundation, Pittsburgh, PA, USA.
Betty KamiraMedical Officer, Makerere University-John Hopkins University, Kampala, Uganda.
Ishana HarkooMedical Officer, Centre for AIDS Programme of Research in South Africa, Durban, South Africa.
Daniel SzydloStatistical Research Associate, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Shorai MukakaMedical Officer, University of Zimbabwe College of Health Sciences Clinical Trials Unit, Harare, Zimbabwe.
Jeanna PiperSenior Officer, Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
Sharon L HillierRichard Sweet Professor of Reproductive Infectious Disease, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
University of Zimbabwe · ZWCentre for the AIDS Programme of Research in South Africa · ZAFred Hutch Cancer Center · USMagee-Womens Research Institute · USMUJHU Research Collaboration · UGNational Institute of Allergy and Infectious Diseases · USPride Foundation · USUniversity of Pittsburgh Medical Center · USUniversity of Washington · US

Funding

Microbicide Trials NetworkUM1AI068633 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI HILLIER, SHARON L. · 2011 to 2021
$175.0M
Statistical and Data Management Center (SDMC): Microbicide Trials NetworkUM1AI068615 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BROWN, ELIZABETH RENATA · 2011 to 2021
$66.5M
University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials UnitUM1AI069469 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI QUARRAISHA ABDOOL KARIM · 2012 to 2026
$36.4M
Laboratory Center (LC): Microbicide Trials NetworkUM1AI106707 · NIAID · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MELLORS, JOHN W, ROHAN, LISA CENCIA · 2014 to 2021
$27.1M
NIAID NIH HHS UM1 AI068615NIAID NIH HHS UM1 AI068633NIAID NIH HHS UM1 AI069469NIAID NIH HHS UM1 AI106707
6 · The paper itself

Abstract

contextThe copper IUD is safe and effective, but underutilized in Sub-Saharan Africa, in part because of a lack of trained providers. The World Health Organization recommends training mid-level providers-including nurses and midwives-to insert IUDs; however, the safety of such task shifting has not been evaluated in Sub-Saharan Africa.

methodsData were drawn from baseline surveys and study charts of 535 sexually active women aged 18-45 who used a copper IUD while participating in an HIV-prevention clinical trial conducted from August 2012 through June 2015 in Malawi, South Africa, Uganda and Zimbabwe. IUDs were inserted by study physicians, nurses and midwives trained as part of the trial, and by local nonstudy providers. Chi-square and Fisher's exact tests were used to compare women's experiences of adverse events-such as irregular bleeding, pelvic pain or device expulsion-by provider type.

resultsHalf (54%) of women reported experiencing an adverse event; the most common were irregular bleeding and pelvic pain (45% and 25%, respectively). Compared with women who had received an IUD from a study physician or study nurse, greater proportions of women who had received one from a nonstudy provider reported any adverse event (76% vs. 49% and 51%, respectively), irregular bleeding (57% vs. 41% and 45%) and pelvic pain (35% vs. 15% and 32%); the difference between study physicians and nurses was significant only for pelvic pain. Expulsion rates were comparable for study nurses and nonstudy providers (12.3 and 11.9 per 100 woman-years, respectively), but lower for study physicians (7.3 per 100 woman-years).

conclusionsThe findings support task shifting of IUD insertion to mid-level providers to improve IUD access in Sub-Saharan Africa.

Indexed as

AdultAllied Health PersonnelAmbulatory CareFeasibility StudiesFemaleHumansIntrauterine Devices, CopperMiddle AgedNurse MidwivesNurse PractitionersPainPelvic Inflammatory DiseasePhysician AssistantsSouth AfricaYoung Adult

Identifiers

PMID31859669
PMCPMC8515488
OpenAlexW2995359669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.